Health Canada has authorized a made-in-Canada COVID-19 vaccine from Medicago, known as Covifenz.
The two-dose xjmtzywvaccine is authorized for use in people aged 18 to 64.
RELATED IMAGESview larger image
Researchers work with equipment in a Medicago facility in this undated handout photo. (Medicago/Handout)
